Observational studyPloS one2016

Renin-Angiotensin System Inhibitors, Type 2 Diabetes and Fibrosis Progression: An Observational Study in Patients with Nonalcoholic Fatty Liver Disease.

Serena Pelusi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.